BPX/ PLDOMEX00010 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-PLN | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2022-03-24
Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2022-01-26
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
GlobeNewswire
2021-12-06
Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Privat...
GlobeNewswire
2021-11-04
Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-09-03
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Confere...
GlobeNewswire
2021-09-01
Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
GlobeNewswire
2021-08-12
Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-07-26
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2021-06-28
Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety ...
GlobeNewswire
2021-05-17
Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-03-30
Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire
2021-03-23
Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
GlobeNewswire
2021-03-04
Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
GlobeNewswire
2021-01-28
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire
2020-11-05
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire
2020-11-04
Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
GlobeNewswire
2020-10-29
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market